Ritholtz Wealth Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Ritholtz Wealth Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.52M	Buy	360,094 +272,559	+311%	+$1.05M	0.02%	501
2026 Q1	$307K	Buy	+87,535	New	+$359K	0.01%	963
2023 Q3	–	Sell	-79,532	Closed	-$846K	–	721
2023 Q2	$846K	Sell	79,532 -140	-0.2%	-$1.5K	0.04%	313
2023 Q1	$838K	Buy	79,672 +8,508	+12%	+$95.3K	0.04%	303
2022 Q4	$882K	Buy	71,164 +22,692	+47%	+$257K	0.05%	254
2022 Q3	$502K	Buy	48,472 +37,348	+336%	+$423K	0.03%	399
2022 Q2	$128K	Buy	+11,124	New	+$131K	0.01%	514

Other funds holding IRWD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Ritholtz Wealth Management's IRWD Position: Q2 2026 in Review

Ritholtz Wealth Management increased its Ironwood Pharmaceuticals (IRWD) stake by 311% in Q2 2026, buying an estimated $1.05M and bringing the position to 360,094 shares worth $1.52M. The position accounts for 0.02% of the portfolio, ranked #501.

Ritholtz Wealth Management first reported a position in IRWD in Q2 2022 and has held it in 7 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

Ritholtz Wealth Management held 360,094 shares of Ironwood Pharmaceuticals worth $1.52M as of Q2 2026.
Ritholtz Wealth Management bought 272,559 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $1.05M.
Ironwood Pharmaceuticals made up 0.02% of Ritholtz Wealth Management's portfolio in Q2 2026, its #501 holding.
Ritholtz Wealth Management first reported a position in Ironwood Pharmaceuticals in Q2 2022 and has held it in 7 quarters since.
212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.